Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Re (RMAX) EBITDA (2016 - 2025)

Re (RMAX) has disclosed EBITDA for 14 consecutive years, with $9.9 million as the latest value for Q4 2025.

  • On a quarterly basis, EBITDA rose 103.61% to $9.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $49.4 million, a 16.12% increase, with the full-year FY2025 number at $49.4 million, up 16.12% from a year prior.
  • EBITDA was $9.9 million for Q4 2025 at Re, down from $18.9 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $18.9 million in Q3 2025 to a low of -$37.6 million in Q3 2021.
  • A 5-year average of $5.5 million and a median of $8.0 million in 2022 define the central range for EBITDA.
  • Peak YoY movement for EBITDA: crashed 501.11% in 2023, then surged 175.3% in 2024.
  • Re's EBITDA stood at $10.4 million in 2021, then fell by 18.88% to $8.5 million in 2022, then crashed by 214.58% to -$9.7 million in 2023, then surged by 150.22% to $4.9 million in 2024, then surged by 103.61% to $9.9 million in 2025.
  • Per Business Quant, the three most recent readings for RMAX's EBITDA are $9.9 million (Q4 2025), $18.9 million (Q3 2025), and $14.6 million (Q2 2025).